New York State Teachers Retirement System Uni Qure N.V. Transaction History

New York State Teachers Retirement System

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	BUY	$18.7 - $23.07 $5,610 - $6,921	300 Added 0.43%	70,800 $1.43 Million
Q4 2022 Jan 27, 2023	BUY	$18.12 - $27.32 $1,812 - $2,732	100 Added 0.14%	70,500 $1.6 Million
Q3 2022 Oct 28, 2022	BUY	$16.98 - $25.54 $730,140 - $1.1 Million	43,000 Added 156.93%	70,400 $1.32 Million
Q2 2022 Aug 01, 2022	BUY	$13.15 - $20.45 $172,265 - $267,895	13,100 Added 91.61%	27,400 $511,000
Q1 2022 Apr 27, 2022	BUY	$14.54 - $21.5 $49,436 - $73,100	3,400 Added 31.19%	14,300 $258,000
Q4 2021 Jan 24, 2022	BUY	$20.24 - $36.01 $30,359 - $54,015	1,500 Added 15.96%	10,900 $226,000
Q3 2021 Oct 25, 2021	BUY	$26.01 - $38.22 $244,494 - $359,268	9,400 New	9,400 $301,000

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of New York State Teachers Retirement System, based on Form 13F filings with the SEC.

Stay updated on New York State Teachers Retirement System with notifications on news.